Aptar Introduces an eDose Counter Aiming to Make Asthma and COPD Inhalers Easier to Use – Lung Disease News


Lung Disease News

Aptar Introduces an eDose Counter Aiming to Make Asthma and COPD Inhalers Easier to Use
Lung Disease News
Aptar Pharma, which specializes in injection, aerosol, and spray delivery systems for healthcare and biotech products, unveiled its newest improvement to metered dose inhaler (MDIs) at the recent RDD scientific conference in Phoenix, Arizona. Aptar's …
Aptar Pharma Launches eDose Counter for Metered Dose Inhalers, with Sensing TechnologyCOPD News Today

all 2 news articles »

View full post on asthma – Google News

Aptar Pharma dose indicator selected for new asthma combination therapy – Packaging World


Packaging World

Aptar Pharma dose indicator selected for new asthma combination therapy
Packaging World
It is indicated for the maintenance treatment of asthma in patients aged 12 years and over, and in adults whose symptoms are not adequately controlled on an ICS and an as-required inhaled short-acting beta2-agonist (SABA), and in those patients who are

View full post on asthma – Google News

Aptar Pharma dose indicator selected for new asthma combination therapy – Healthcare Packaging

Aptar Pharma dose indicator selected for new asthma combination therapy
Healthcare Packaging
It is indicated for the maintenance treatment of asthma in patients aged 12 years and over (50/5?g and 125/5?g strengths), and in adults (250/10?g strength) whose symptoms are not adequately controlled on an ICS and an as-required inhaled short-acting

View full post on asthma – Google News

Aptar Pharma celebrates asthma day with a twister™ of innovation – Packaging Europe


Packaging Europe

Aptar Pharma celebrates asthma day with a twister™ of innovation
Packaging Europe
World leader in the development and manufacturing of nasal and pulmonary drug delivery devices including inhalers for asthma, Aptar Pharma launches Twister™, a new versatile affordable capsule-based Dry Powder Inhaler (DPI) specifically targeting fast

View full post on asthma – Google News